Page 5 - Dhepa News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Dhepa. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Dhepa Today - Breaking & Trending Today

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA) Sees Significant Growth in Short Interest

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA – Free Report) saw a significant growth in short interest in June. As of June 15th, there was short interest totalling 364,100 shares, a growth of 52.9% from the May 31st total of 238,200 shares. Approximately 9.6% of the shares of the stock are short sold. Based on an average daily […] ....

United States , News Ratings For Hepion Pharmaceuticals Daily , Hepion Pharmaceuticals Company Profile , Envestnet Asset Management Inc , Virtu Financial , Renaissance Technologies , Hepion Pharmaceuticals Inc , Hepion Pharmaceuticals Trading , Blackrock Inc , Hepion Pharmaceuticals , Free Report , Street Corp , Asset Management , Hepion Pharmaceuticals Daily , Nasdaq Hepa ,

Hepion Pharmaceuticals (NASDAQ:HEPA) Trading Down 0.9%

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA – Get Rating) shares dropped 0.9% during mid-day trading on Monday . The stock traded as low as $10.35 and last traded at $10.44. Approximately 129,096 shares were traded during trading, a decline of 41% from the average daily volume of 218,564 shares. The stock had previously closed at $10.54. Hepion […] ....

United States , Renaissance Technologies , Blackrock Inc , Virtu Financial , Hepion Pharmaceuticals Company Profile , Hepion Pharmaceuticals Stock Performance , Envestnet Asset Management Inc , Hepion Pharmaceuticals , News Ratings For Hepion Pharmaceuticals Daily , Hedge Funds Weigh In On Hepion Pharmaceuticals , Hepion Pharmaceuticals Inc , Get Rating , Asset Management , Street Corp , Hepion Pharmaceuticals Daily , Nasdaq Hepa ,

Fairfield Bush & CO. Decreases Stock Position in PepsiCo, Inc. (NASDAQ:PEP)

Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA – Get Rating) was down 0.9% during trading on Monday . The stock traded as low as $10.35 and last traded at $10.44. Approximately 129,096 shares changed hands during mid-day trading, a decline of 41% from the average daily volume of 218,564 shares. The stock had previously closed at $10.54. Hepion […] ....

United States , Blackrock Inc , News Ratings For Hepion Pharmaceuticals Daily , Renaissance Technologies , Hepion Pharmaceuticals Inc , Hepion Pharmaceuticals , Hepion Pharmaceuticals Stock Performance , Hepion Pharmaceuticals Company Profile , Virtu Financial , Envestnet Asset Management Inc , Get Rating , Asset Management , Street Corp , Hepion Pharmaceuticals Daily , Nasdaq Hepa ,